サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1544121

経皮ドラッグデリバリーの世界市場

Transdermal Drug Delivery

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
経皮ドラッグデリバリーの世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経皮ドラッグデリバリーの世界市場は2030年までに2,353億米ドルに達する見込み

2023年に806億米ドルと推定される経皮ドラッグデリバリーの世界市場は、2023年から2030年にかけてCAGR 16.5%で成長し、2030年には2,353億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるパッシブデリバリーは、CAGR 15.1%を記録し、分析期間終了時には1,235億米ドルに達すると予測されます。アクティブデリバリーセグメントの成長率は、分析期間中CAGR 18.4%と推定されます。

米国市場は221億米ドルと推定、中国はCAGR 15.7％で成長予測

米国の経皮ドラッグデリバリー市場は2023年に221億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに356億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは15.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ15.1%と14.2%と予測されています。欧州では、ドイツがCAGR約14.6%で成長すると予測されています。

世界の経皮ドラッグデリバリー市場- 主要動向と促進要因まとめ

経皮ドラッグデリバリーとは何か、なぜ重要なのか？

経皮ドラッグデリバリーとは、制御された方法で皮膚から薬剤を投与し、全身的な効果を得る方法です。このドラッグデリバリーシステムは、非侵襲的で、便利で、効果的な方法で、消化管を迂回し、血流に直接薬剤を送り込むために非常に重要です。経皮パッチは経皮ドラッグデリバリーシステムの最も一般的な形態であり、慢性疼痛、ホルモン不均衡、ニコチン中毒など様々な症状の治療に使用されています。経皮ドラッグデリバリーの意義は、患者のコンプライアンスを向上させ、副作用のリスクを軽減し、長期間にわたり治療薬レベルを一定に保つことができる点にあります。

経皮ドラッグデリバリーはどのように治療結果を改善するのでしょうか？

経皮ドラッグデリバリーは、薬剤をコントロールされた状態で持続的に放出することにより、治療成績を向上させます。このデリバリー方法により、薬剤は安定した速度で吸収され、血流中の最適な治療レベルを維持します。消化管をバイパスすることで、経皮システムは胃刺激や初回通過代謝などの問題を回避し、薬剤が全身循環に到達する前に分解される可能性があります。このため、バイオアベイラビリティが向上し、必要な投与量が減少します。さらに、経皮パッチは使い勝手がよく、自己投与が可能であるため、処方された治療レジメンに対する患者のアドヒアランスが向上します。これらの利点は総合的に、より効果的で信頼性の高い治療結果に貢献します。

なぜ経皮ドラッグデリバリーシステムの需要が増加しているのでしょうか？

経皮ドラッグデリバリーシステムの需要は、いくつかの重要な要因により増加しています。長期的な投薬管理を必要とする慢性疾患や病態の蔓延が、便利で効果的なドラッグデリバリー方法の必要性を高めています。薬物製剤と皮膚浸透技術の進歩により、経皮投与可能な薬物の範囲が拡大し、その適用性が高まっています。また、患者のコンプライアンスを向上させ、頻繁な投与レジメンの負担を軽減するという焦点も、経皮システムの需要を促進しています。さらに、経皮ドラッグデリバリーの非侵襲性は、注射や経口薬を避けたい患者にとって魅力的な選択肢となっています。新しい経皮技術の開発とヘルスケア業界におけるこれらのシステムの受け入れ拡大は、その採用をさらに後押ししています。

経皮ドラッグデリバリー市場の成長を促進する要因は？

経皮ドラッグデリバリー市場の成長は、いくつかの要因によって牽引されています。慢性疾患や長期にわたる投薬が必要な疾患の有病率の増加により、効果的で利便性の高いドラッグデリバリーシステムに対する大きな需要が生じています。薬剤製剤、皮膚浸透促進剤、パッチデザインにおける技術の進歩は、経皮デリバリーシステムの有効性と範囲を拡大し、その採用を促進します。また、患者のコンプライアンス向上への注目や、非侵襲的ドラッグデリバリーオプションへのニーズも市場成長に寄与しています。疼痛管理、ホルモン補充療法、禁煙など、経皮吸収システムの用途が拡大していることも、需要をさらに押し上げています。さらに、有利な規制政策と新規経皮技術の開拓が市場拡大を支えています。ヘルスケア業界における経皮ドラッグデリバリーの受け入れ拡大に加え、その性能と信頼性を高めるための研究開発の継続的な取り組みが、市場の成長の可能性を裏付けています。

調査対象企業の例（全12件）

  • Antares Pharma, Inc.
  • Bayer AG
  • Durect Corporation
  • Iontera, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • Novartis AG
  • Pantec Biosolutions AG
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15288

Global Transdermal Drug Delivery Market to Reach US$235.3 Billion by 2030

The global market for Transdermal Drug Delivery estimated at US$80.6 Billion in the year 2023, is expected to reach US$235.3 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Passive Delivery, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$123.5 Billion by the end of the analysis period. Growth in the Active Delivery segment is estimated at 18.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$22.1 Billion While China is Forecast to Grow at 15.7% CAGR

The Transdermal Drug Delivery market in the U.S. is estimated at US$22.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$35.6 Billion by the year 2030 trailing a CAGR of 15.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.1% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global Transdermal Drug Delivery Market - Key Trends & Drivers Summarized

What is Transdermal Drug Delivery and Why is it Crucial?

Transdermal Drug Delivery is a method of administering medications through the skin in a controlled manner to achieve systemic effects. This delivery system is crucial for providing a non-invasive, convenient, and effective way of delivering drugs directly into the bloodstream, bypassing the gastrointestinal tract. Transdermal patches are the most common form of transdermal drug delivery systems, used to treat various conditions such as chronic pain, hormonal imbalances, and nicotine addiction. The significance of transdermal drug delivery lies in its ability to improve patient compliance, reduce the risk of side effects, and maintain consistent therapeutic drug levels over extended periods.

How Does Transdermal Drug Delivery Improve Therapeutic Outcomes?

Transdermal Drug Delivery improves therapeutic outcomes by offering a controlled and sustained release of medication. This delivery method ensures that drugs are absorbed at a steady rate, maintaining optimal therapeutic levels in the bloodstream, which enhances efficacy and reduces the frequency of dosing. By bypassing the gastrointestinal tract, transdermal systems avoid issues such as gastric irritation and first-pass metabolism, which can degrade the drug before it reaches systemic circulation. This leads to better bioavailability and reduced dosage requirements. Additionally, transdermal patches are user-friendly and can be self-administered, improving patient adherence to prescribed treatment regimens. These benefits collectively contribute to more effective and reliable therapeutic outcomes.

Why is the Demand for Transdermal Drug Delivery Systems Increasing?

The demand for Transdermal Drug Delivery systems is increasing due to several key factors. The rising prevalence of chronic diseases and conditions that require long-term medication management drives the need for convenient and effective drug delivery methods. Advances in drug formulation and skin penetration technologies have expanded the range of drugs that can be delivered transdermally, increasing their applicability. The focus on improving patient compliance and reducing the burden of frequent dosing regimens also fuels the demand for transdermal systems. Additionally, the non-invasive nature of transdermal drug delivery makes it an attractive option for patients who prefer to avoid injections or oral medications. The development of novel transdermal technologies and the growing acceptance of these systems in the healthcare industry further support their adoption.

What Factors are Driving the Growth of the Transdermal Drug Delivery Market?

The growth in the Transdermal Drug Delivery market is driven by several factors. The increasing prevalence of chronic diseases and conditions requiring long-term medication creates a significant demand for effective and convenient drug delivery systems. Technological advancements in drug formulation, skin penetration enhancers, and patch design enhance the efficacy and range of transdermal delivery systems, driving their adoption. The focus on improving patient compliance and the need for non-invasive drug delivery options also contribute to market growth. The expanding applications of transdermal systems, including pain management, hormone replacement therapy, and smoking cessation, further boost demand. Additionally, favorable regulatory policies and the development of novel transdermal technologies support market expansion. The growing acceptance of transdermal drug delivery in the healthcare industry, coupled with ongoing research and development efforts to enhance their performance and reliability, underscores the market's potential for growth.

Select Competitors (Total 12 Featured) -

  • Antares Pharma, Inc.
  • Bayer AG
  • Durect Corporation
  • Iontera, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • Novartis AG
  • Pantec Biosolutions AG
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transdermal Drug Delivery - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Preference for Non-Invasive Drug Delivery Methods
    • Advancements in Patch Technology and Formulations
    • Increasing Incidence of Chronic Diseases
    • Rising Demand for Controlled Release and Targeted Delivery
    • Expansion of Applications Beyond Pain Management
    • Market Growth in Geriatric and Pediatric Populations
    • Impact of Biotechnology and Nanotechnology Innovations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Transdermal Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Active by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Smoking Cessation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Smoking Cessation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Smoking Cessation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transdermal Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION